Lithium Carbonate Tablet, Extended Release
Product Images NDC 72789-171

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 72789-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789171)

This text is a label for Lithium Carbonate extended-release tablets. Each tablet contains 300 mg of lithium carbonate. The recommended adult dose should be consulted in the package insert. The tablets should be stored at 20° to 25°C, protected from moisture. It warns to see the package insert for more information. The tablets are tamper-evident and should not be used if the seal is broken. Manufactured by West-Ward Pharmaceuticals, Columbus, Ohio, and marketed by PD-Rx Pharmaceuticals, Inc, Oklahoma City. Keep out of reach of children. Contains 500 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.